Literature DB >> 23217164

Mitochondrial proteomics of nasopharyngeal carcinoma metastasis.

Jianping Liu1, Xianquan Zhan, Maoyu Li, Guoqing Li, Pengfei Zhang, Zhefeng Xiao, Meiying Shao, Fang Peng, Rong Hu, Zhuchu Chen.   

Abstract

BACKGROUND: Mitochondrial proteomic alterations of nasopharyngeal carcinoma metastasis remain unknown. Our purpose is to screen mitochondrial proteins for the elucidation of the molecular mechanisms of nasopharyngeal carcinoma metastasis and the discovery of metastasis-related biomarkers.
METHODS: Mitochondria were isolated from nasopharyngeal carcinoma metastatic (5-8F) and nonmetastatic (6-10B) cell lines, respectively. After characterization of isolated mitochondria, mitochondrial differentially expressed proteins (DEPs) were quantified by two-dimensional difference in-gel electrophoresis (2D-DIGE), and identified by peptide mass fingerprint (PMF) and tandem mass spectrometry (MS/MS). A functional enrichment analysis and a protein-protein interaction sub-network analysis for DEPs were carried out with bioinformatics. Furthermore, siRNAs transient transfections were used to suppress expressions of some up-regulated DEPs in metastatic cells (5-8F), followed by Transwell Migration assay.
RESULTS: Sixteen mitochondrial DEPs including PRDX3 and SOD2 were identified. Those 5-8F cells with suppression of PRDX3 showed an increased mobility potential. The functional enrichment analyses of DEPs discovered five significant biological processes including cellular response to reactive oxygen species, hydrogen peroxide metabolic process, regulation of mitochondrial membrane potential, cell redox homeostasis and oxidation reduction, and five significant molecular functions including oxidoreductase activity, caspase inhibitor activity, peroxiredoxin activity, porin activity and antioxidant activity. A protein-protein interaction sub-network of DEPs was generated with literature data. Ten mitochondrial DEPs including PRDX3, PRDX6, SOD2, ECH1, SERPINB5, COX5A, PDIA5, EIF5A, IDH3B, and PSMC4 were rationalized in the tumor-stroma co-evolution model that mitochondrial oxidative stress directly contributes to tumor metastasis.
CONCLUSIONS: Sixteen mitochondrial DEPs were identified with mass spectrometry and ten of them were rationalized in the tumor-stroma co-evolution model. Those 5-8F cells with suppression of PRDX3 showed an increased mobility potential. These data suggest that those mitochondrial DEPs are potential biomarkers for NPC metastasis, and their dysregulation would play important roles in mitochondria oxidative stress-mediated NPC metastatic process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23217164      PMCID: PMC3539862          DOI: 10.1186/1755-8794-5-62

Source DB:  PubMed          Journal:  BMC Med Genomics        ISSN: 1755-8794            Impact factor:   3.063


  41 in total

1.  Significance of immunohistochemical expression of manganese superoxide dismutase as a marker of malignant potential in colorectal carcinoma.

Authors:  Tadahiro Nozoe; Masayuki Honda; Sadaaki Inutsuka; Mitshuhiro Yasuda; Daisuke Korenaga
Journal:  Oncol Rep       Date:  2003 Jan-Feb       Impact factor: 3.906

2.  Phospholipase A2 activity of peroxiredoxin 6 promotes invasion and metastasis of lung cancer cells.

Authors:  Jin-Nyoung Ho; Seung Bum Lee; Seung-Sook Lee; Sung Hwan Yoon; Ga Young Kang; Sang-Gu Hwang; Hong-Duck Um
Journal:  Mol Cancer Ther       Date:  2010-03-30       Impact factor: 6.261

Review 3.  Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment.

Authors:  Michael P Lisanti; Ubaldo E Martinez-Outschoorn; Barbara Chiavarina; Stephanos Pavlides; Diana Whitaker-Menezes; Aristotelis Tsirigos; Agnieszka Witkiewicz; Zhao Lin; Renee Balliet; Anthony Howell; Federica Sotgia
Journal:  Cancer Biol Ther       Date:  2010-09-19       Impact factor: 4.742

4.  Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma.

Authors:  Dong-Jiang Tang; Sui-Sui Dong; Ning-Fang Ma; Dan Xie; Leilei Chen; Li Fu; Sze Hang Lau; Yan Li; Yan Li; Xin-Yuan Guan
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

5.  Identification and functional characterization of a novel, tissue-specific NAD(+)-dependent isocitrate dehydrogenase beta subunit isoform.

Authors:  Y O Kim; H J Koh; S H Kim; S H Jo; J W Huh; K S Jeong; I J Lee; B J Song; T L Huh
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

6.  Increased activity of superoxide dismutase in advanced stages of head and neck squamous cell carcinoma with locoregional metastases.

Authors:  R Salzman; K Kanková; L Pácal; J Tomandl; Z Horáková; R Kostrica
Journal:  Neoplasma       Date:  2007       Impact factor: 2.575

7.  Molecular cloning and nucleotide sequence of cDNAs encoding the alpha-subunit of human electron transfer flavoprotein.

Authors:  G Finocchiaro; M Ito; Y Ikeda; K Tanaka
Journal:  J Biol Chem       Date:  1988-10-25       Impact factor: 5.157

8.  hNOA1 interacts with complex I and DAP3 and regulates mitochondrial respiration and apoptosis.

Authors:  Tingdong Tang; Bin Zheng; Sheng-Hong Chen; Anne N Murphy; Krystyna Kudlicka; Huilin Zhou; Marilyn G Farquhar
Journal:  J Biol Chem       Date:  2008-12-22       Impact factor: 5.157

9.  Arsenic-based antineoplastic drugs and their mechanisms of action.

Authors:  Stephen John Ralph
Journal:  Met Based Drugs       Date:  2008

10.  Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.

Authors:  Xin-Zhong Chang; Da-Qiang Li; Yi-Feng Hou; Jiong Wu; Jin-Song Lu; Gen-Hong Di; Wei Jin; Zhou-Luo Ou; Zhen-Zhou Shen; Zhi-Ming Shao
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more
  14 in total

1.  Comparative membrane proteomic analysis between lung adenocarcinoma and normal tissue by iTRAQ labeling mass spectrometry.

Authors:  Xuede Zhang; Wei Li; Yanli Hou; Zequn Niu; Yujie Zhong; Yuping Zhang; Shuanying Yang
Journal:  Am J Transl Res       Date:  2014-05-15       Impact factor: 4.060

Review 2.  The interaction between mitochondria and oncoviruses.

Authors:  Shujie Song; Shasha Gong; Pragya Singh; Jianxin Lyu; Yidong Bai
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-09-28       Impact factor: 5.187

Review 3.  A Review: Proteomics in Nasopharyngeal Carcinoma.

Authors:  Ze-Tan Chen; Zhong-Guo Liang; Xiao-Dong Zhu
Journal:  Int J Mol Sci       Date:  2015-07-08       Impact factor: 5.923

Review 4.  Omics-based identification of biomarkers for nasopharyngeal carcinoma.

Authors:  Tavan Janvilisri
Journal:  Dis Markers       Date:  2015-04-27       Impact factor: 3.434

5.  Peroxiredoxin-6 Negatively Regulates Bactericidal Activity and NF-κB Activity by Interrupting TRAF6-ECSIT Complex.

Authors:  Yoon Min; Sae M Wi; Dongwoo Shin; Eunyoung Chun; Ki-Young Lee
Journal:  Front Cell Infect Microbiol       Date:  2017-03-24       Impact factor: 5.293

6.  Comparative mitochondrial proteomic analysis of human large cell lung cancer cell lines with different metastasis potential.

Authors:  Zhenkun Liu; Song Xu; Lu Li; Xiaorong Zhong; Chun Chen; Yaguang Fan; Wang Shen; Lingling Zu; Feng Xue; Min Wang; Qinghua Zhou
Journal:  Thorac Cancer       Date:  2019-04-04       Impact factor: 3.500

7.  Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer.

Authors:  Rong Hu; Xiaowei Wang; Xianquan Zhan
Journal:  EPMA J       Date:  2013-01-22       Impact factor: 6.543

8.  Identification of nasopharyngeal carcinoma metastasis-related biomarkers by iTRAQ combined with 2D-LC-MS/MS.

Authors:  Zhen Chen; Lu Long; Kun Wang; Facai Cui; Lepan Zhu; Ya Tao; Qiong Wu; Manlin Xiang; Yunlai Liang; Shiyang Qiu; Zhiqiang Xiao; Bin Yi
Journal:  Oncotarget       Date:  2016-06-07

9.  Changes in the in vitro activity of platinum drugs when administered in two aliquots.

Authors:  Zaynab Al-Eisawi; Philip Beale; Charles Chan; Jun Qing Yu; Nicholas Proschogo; Mark Molloy; Fazlul Huq
Journal:  BMC Cancer       Date:  2016-08-26       Impact factor: 4.430

10.  Biomarkers of tumor invasiveness in proteomics (Review).

Authors:  Daniel L Pouliquen; Alice Boissard; Olivier Coqueret; Catherine Guette
Journal:  Int J Oncol       Date:  2020-05-28       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.